Rohrer Aesthetics, a manufacturer of energy-based aesthetic technology founded in 2014, recently conducted a clinical study evaluating its PIX:E device. The study evaluated the device's ability to rejuvenate skin and prevent visible signs of aging before they begin using collagen-induction technologies, showing 91% efficacy.
PIX:E combines FDA-cleared 4MHz radiofrequency microneedling system with fractional and full-field Er:YAG laser resurfacing, per a July 1 press release. Looking at the device’s potential to deeply stimulate collagen and facilitate skin rejuvenation in a single session, Rohrer assessed 20 patients in the study.
Of those participants, 91%, all of which present diverse skin types, reported improvements in skin tone and texture, including those with sensitive and deeper skin tones, per the release.
PIX:E decided to integrate these specific modalities, including its microneedling and laser features, to intervene in the aging process early, not mitigate it after aging signs occur. It specifically stimulates Type I collagen, designed to alleviate the appearances of abdomiminal laxity, stretch marks, acne scars and wrinkles.
Uneven tone and texture, enlarged pores, sun damage and hypertrophic scars can also be targeted using this device, addressing surface-level and deeper dermal layers, per the release.
"We created PIX:E to simplify and elevate the way practices approach skin rejuvenation," said Liz Smith, chief marketing officer at Rohrer. "What's most compelling, however, is the impact this has for patients–it represents a shift toward truly proactive care, allowing individuals to address the aging process before visible signs appear."
